Nano Drug Delivery Offers New Possibilities for Pulmonary Fibrosis

Jason McCarthy, Ph.D., Scientific Operations Director and Associate Professor at MMRI, led new research in nano drug delivery that reveals new possibilities for the treatment of pulmonary fibrosis.

Phys.org: Nano drug delivery breakthrough reveals new possibilities for the treatment of pulmonary fibrosis

https://phys.org/news/2023-02-nano-drug-delivery-breakthrough-reveals.html (Click here for the PDF)

AZO Nano: Nano Drug Brings New Treatment Possibilities to Pulmonary Fibrosis

https://www.azonano.com/news.aspx?newsID=40042 (Click here for the PDF)

Lab Manager: New Possibilities for the Treatment of Pulmonary Fibrosis

https://www.labmanager.com/news/new-possibilities-for-the-treatment-of-pulmonary-fibrosis-29715 (Click here for the PDF)

Daily Sentinel: MMRI research reveals new possibilities for treatment of pulmonary fibrosis

https://romesentinel.com/stories/mmri-research-reveals-new-possibilities-for-treatment-of-pulmonary-fibrosis,163637

Original Study:

Knipe, R. S., et al. (2023) Myofibroblast-Specific Inhibition of the Rho Kinase-MRTF-SRF Pathway Using Nanotechnology for the Prevention of Pulmonary Fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. doi:10.1152/ajplung.00086.2022